Glabridin inhibited the spread of polymyxin-resistant Enterobacterium carrying ICE

Jiafang Fu1,2, Yayu Liu1,2, Fengtian Wang3

  • 1First Affiliated Hospital of Shandong First Medical University, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.

PubMed
Abstract

Insights

A novel integrative and conjugative element (ICE), ICEMmoMP63, was identified in Morganella morganii, conferring polymyxin resistance. This ICE can transfer between bacteria, and glabridin may inhibit polymyxin resistance.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • Integrative and conjugative elements (ICEs) are mobile genetic elements with largely unknown roles in antibiotic resistance in Morganella morganii.
  • Polymyxin resistance is a growing public health concern, necessitating research into its genetic underpinnings.

Purpose of the Study:

  • To investigate the contribution of an identified ICE in M. morganii to polymyxin resistance.
  • To determine the transferability and mechanisms of antibiotic resistance conferred by the ICE.

Main Methods:

  • Whole-genome sequencing and bioinformatics analyses were used to identify ICEs and antibiotic resistance genes.
  • Conjugation assays and heterologous expression in Escherichia coli were performed to assess ICE transferability and function.
  • Minimum inhibitory concentrations were determined, and a traditional Chinese medicine library was screened for efflux pump inhibitors.

Main Results:

  • An ICE, designated ICEMmoMP63, was identified and confirmed to be horizontally transferable among Enterobacteriaceae.
  • A gene (G3577_03020) on ICEMmoMP63 was found to mediate multiple antibiotic resistances, particularly to polymyxins.
  • The natural compound glabridin demonstrated inhibitory effects on polymyxin resistance.

Conclusions:

  • Monitoring the dissemination of ICEMmoMP63 in Enterobacteriaceae is crucial due to its role in antibiotic resistance.
  • Combination therapy with glabridin and polymyxin shows potential for treating infections caused by multi-drug resistant bacteria carrying ICEMmoMP63.